LETTER TO THE EDITOR

The role of the hypertension specialists
We reply to Dr Beevers' Commentary which dealt with the American Society of Hypertension (ASH) initiative to identify and recognise 'Specialists in Clinical Hypertension' as made public at the May 1998 Scientific Meeting of the Society. 1 First, and foremost, we thank Dr Beevers for a thoughtful and perceptive analysis of a difficult problem. To rephrase his questions: What justifies another medical specialty when so many hypertensives need access to a responsive informed 'primary' health care provider such as a general practitioner or qualified nurse practitioner? Aren't there enough cardiologists, nephrologists and endocrinologists around to deal with the very rare situations: eg, phaeochromocytoma, renal artery stenosis, or coarctation of the aorta? Similarly, can't the clinical pharmacologists provide sufficient expertise for the refractory hypertensives and those with multiple risk factors who need complex combinations of drug therapy? Hypertension is a disorder of blood pressure regulation, not a specific disease, so why recognise specialists for quantitative deviation from the normal? Isn't it like having a specialty for fever, rather than for infectious diseases?
The deliberations of the ASH Working Committee on the Hypertension Specialist addressed these issues in relation to the size and complexity of the 'hypertension problem'. Together with Dr Beevers, we were struck by the failure to achieve better control of hypertension in the United States as documented in the most recent report of the National Health and Nutrition Survey (NHANES). 2 Given the high prevalence of hypertension in the adult population and evidence that treating hypertension is beneficial based on old and recent clinical trials, 3-5 our concern was the need for several innovative strategies to improve the treatment of hypertension. Simply put, we concluded that the magnitude of the problem implies a multipronged battle plan incorporating all of Dr Beevers' suggestions rather than having to choose, either/or, among them.
Yes, those in general or family practice and internists whether physicians or nurse practitioners should be the front-line for care and management of the vast majority of hypertensive patients. In general, these providers will be community based with varying ties to university faculties and clinics. They should be well informed about hypertension and reasonably sophisticated in strategies for its care. However, with the progressively increasing burden on primary care providers to do as well for the ever-increasing spectrum of disorders from the 'risk factors' of diabetes, hyperlipidaemia and hypertension to those with target organ pathology, angina, heart failure, claudication, but also the non-cardiovascular diseases, how can one do the best job for each patient? As to the existing medical specialties (eg, cardiology or nephrology), the variety in their training programmes and differing focus of their activities does not guarantee that any one specialist will be skilled in consulting on hypertension related problems.
In our presentation to the ASH, we specifically made the point that keeping up with the knowledge base for hypertension alone (ie, publications), together with the variety and complexity of diagnostic tests and new treatments has become a daunting task for any one expert clinician, let alone those in the trenches of primary care. Furthermore, we acknowledged that there already are, in our midst, many clinicians who are specifically interested in hypertension and already do function as the local experts as a resource to their colleagues. Some, not all, are based in academic medical centres. Our initial step was to identify and recognise as many as possible, initially through review of memberships of the American Society of Hypertension and the Council for High Blood Pressure Research of the American Heart Association. We then queried the deans and department chairs of schools of medicine and osteopathy for their suggestions for finding more local and regional experts. This process admittedly favours the academically affiliated, but we have not stopped at that point. The process will become open to those seeking recognition by submitting their qualifications and, as the next phase, passing a suitably designed examination.
No 'Specialist in Clinical Hypertension' will be an expert in all related areas, but most and perhaps all, we anticipate will serve as identifiable resources to local clinicians and, in time, to health systems for the long range goal of better care for the diverse and large population having hypertension. One in five Americans has hypertension that needs attention. Inevitably, most will be cared for by generalists. Some fraction of these 40 million will have conditions sufficiently complex to require the care of a specialist. Perhaps even more importantly, we see the hypertension specialist being a resource for generalists in and out of managed care to ensure that the best of diagnostic and therapeutic care is provided to each patient-no matter who provides that care. 
